We spoke with Bob Proulx, CEO Imagion Biosystems, about Imagion’s revolutionary MagSense imaging technology, which is potentially orders of magnitude more effective than CT and MRI at detecting cancer. MagSense was granted Breakthrough Device status by the FDA in June 2019 and is currently being prepared for its first clinical study, potentially in Her2-positive breast […] [Read more...]
Space-powered Radio Frequency Reconnaissance data-as-a-service company Kleos Space (ASX: KSS) has signed a contract with rideshare provider Spaceflight Inc to … [Read more...]
Osprey Medical, Inc. (ASX:OSP) has received critical European CE Marking approval for its 2ndgeneration DyeVert Power XT device. President and CEO, Mike … [Read more...]
NEWTON, Mass. and PETACH TIKVA, Israel – August 13, 2020 CyberArk (NASDAQ: CYBR), today announced it was named a Leader in the Gartner 2020 Magic Quadrant … [Read more...]
EcoGraf Limited (ASX: EGR) continues to obtain positive results from its electrochemical analysis of preferred feedstocks for its proposed EcoGraf battery … [Read more...]
Personalised cancer medicine developer Prescient Therapeutics (ASX: PTX) is proceeding with the Phase 1b study of its PTX-100 agent will proceed to the next … [Read more...]
Ardea Resources Limited (ASX:ARL) has commenced a research project with Australia’s national science agency the CSIRO’s Regolith Geosciences team studying the … [Read more...]
Paradigm Biopharmaceuticals Ltd (ASX: PAR) has achieved a number of critical developments required to progress investigation into the use of its core drug … [Read more...]
Next generation memory technology developer Weebit Nano (ASX: WBT) has successfully completed the first stage of the “stabilisation” process, a key milestone on … [Read more...]
Over the last few months, work life for many has transformed dramatically - from commuting into work and catching up with colleagues and clients in person, to … [Read more...]
XTEK Limited (ASX:XTE) has been included in Team C4 EDGE(Evolutionary Digital Ground Environment), where it will collaborate with other Australian companies to … [Read more...]
Emerald Clinics Limited (ASX: EMD) has been engaged by Spectrum Biomedical UK (SBUK), the UK subsidiary of the world’s largest cannabis company Canopy Growth, … [Read more...]
Natural skin care company Skin Elements Limited (ASX: SKN) has entered into a binding distribution agreement with Prudential Consultants Pty Ltd for the … [Read more...]